Zhou ,November 2016 . .Clinical utility of serum cystatin c in predicting diabetic nephropathy among patients with diabetes mellitus: a meta-analysis. ” Kidney and Blood Pressure Research, 41(6) : 919-928.
Xin- .2020 .Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in China: A metaanalysis of observational studies. ” Journal of Diabetes Research, 1 : .
Shahwan Moyad,Jamal Moyad,April 2019 . .Prevalence of diabetic nephropathy and associated risk factors among type 2 diabetes mellitus patients in Ramallah, Palestine. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(2) : 1491-1496.
Amorim Rayne,Gomes Rayne .2019 .ht ml&lang=en.. , 112 : 577-587.
Pham ,April 2012 . .Chronic kidney disease, insulin resistance, and incident diabetes in older adults. Clinical Journal of the American Society of Nephrology, 7(4) : 588-594.
Spoto .2016 .Insulin resistance in chronic kidney disease: a systematic review. American Journal of Physiology-Renal Physiology, 311(6) : F1087-F1108.
Feingold K. R.,Grunfeld C. .2000 .Introduction to lipids and lipoproteins. , : .
Magnussen . .Factors affecting the stability of blood lipid and lipoprotein levels from youth to adulthood: evidence from the Childhood Determinants of Adult Health Study. Archives of Pediatrics & Adolescent Medicine, 165(2011) : 68-76.
Brandão Maria,Piedade Maria .2035 .Impacto de la exposición académica en el estado de salud de estudiantes universitarios. , 45 : 49-58.
Go A.S.,Chertow G.M.,Fan D.,Mcculloch C.E.,Hsu C.Y. .2004 .Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. ” Engl. J. Med, 351 : 1296-1305.
Jayarama N. . .Prevalence and pattern of dyslipidemia in type 2 diabetes mellitus patients in a rural tertiary care centre, southern India. Global Journal of Medicine & Public Health, 1(2012) : 24-28.
Yang . .Effects of albuminuria and renal dysfunction on development of dyslipidaemia in type 2 diabetes-the Hong Kong Diabetes Registry. Nephrology Dialysis Transplantation, 23(2008) : 2834-2840.
Ravid .1998 .Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Archives of Internal Medicine, 158(9) : 998-1004.
Kolhar U. . .. International Journal of Advances in Medicine.” International Journal of Advances in Medicine, 4(2017) : 1513-1516.
Jisieike-Onuigbo N. N. . .Prevalence of dyslipidemia among adult diabetic patients with overt diabetic nephropathy in Anambra state South-East Nigeria. Nigerian Journal of Clinical Practice, 14(2011) : 171-175.
Huang ,Po- .2022 .“2022 Taiwan lipid guidelines for primary prevention. ” Journal of the Formosan Medical Association, 121(12) : 2393-2407.
Zolezzi M. “ .2006 .Management of dyslipidemia in renal disease and transplantation. Saudi Journal of Kidney Diseases and Transplantation, 17 : 129-136.
Rahman . .Ser um_Lipids_and_Lipoproteins_with.9.aspx. Clinical journal of the American Society of Nephrology, 9(2014) : 1190-1198.